Skip to main content
. 2017 Jun 22;2017(6):CD011947. doi: 10.1002/14651858.CD011947.pub2

Banks 1994c.

Methods RCT; participants randomised (only 1 wound per person)
 Funding: industry funded ‐ CV Laboratories Ltd (foam manufacturer) and Calgon Vestal Laboratories (HC manufacturer). Setting: hospital inpatients
 Duration of follow‐up 6 weeks
 Unit of analysis: person (1 ulcer/person)
Participants 29 participants with pressure ulcers. PU Stage: II and III (involving loss of skin) proportions not stated (PU classification: not stated)
 Age: median (range): 74 (40‐95) years and 73 (40‐88) years. Duration of ulcer: median (range): 5.5 (2‐365) days and 7 (2‐14) days. Ulcer size: median (range): 2.4 (0.1‐25.8) and 1.4 (0.5‐14.3) cm²
 Wound characteristics at baseline: no wounds infected; slough not reported; no wounds necrotic; exudate moderate levels
Interventions Group 1: hydrocolloid dressing ‐ Granuflex: Granuflex E; additional support therapy for immobile participants; n = 16. Grouped intervention category: advanced dressing
 Group 2: foam dressing ‐ Spyrosorb (not in BNF) (additional support therapy for immobile participants); n = 13). Grouped intervention category: advanced dressing
Outcomes Primary outcomes: proportion completely healed at 6 weeks; time to complete healing not reported
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Selection bias Unclear risk Sequence generation unclear ‐ “randomised”. Allocation concealment unclear ‐ no information on allocation concealment. Baseline comparability unclear ‐ baseline difference but unclear of importance. Rating: unclear
Blinding of outcome assessment (detection bias) 
 All outcomes High risk Not blinded ('open label') and no evidence that outcome assessor was blinded
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Missing data: Group 1 ‐ 4/16 (25%) (3 wound deterioration, 1 wound/dressing‐related problems). Group 2 ‐ 3/13 (23%) (1 wound deterioration, 1 wound/dressing‐related problems, 1 discharged from hospital)
 i.e. similar rate missing in both groups; low rate ‐ less than control event rate
Selective reporting (reporting bias) High risk Inadequate – outcome included in methods section but not results
Other bias 
 unit of analysis Low risk Unit of randomisation person and unit of analysis person (1 ulcer/person)
Other bias 
 additional Unclear risk Insufficient information to assess whether an important risk of bias exists
ALL‐DOMAIN RISK OF BIAS High risk Rating: high
 Reasons: unclear selection bias, not blinded, baseline differences
 Comments: wound area showed no significant difference, but median 2.4 versus 1.4; Grade II assumed to be acceptable (loss of skin tissue)